T
Thomas Danne
Researcher at Hannover Medical School
Publications - 293
Citations - 10568
Thomas Danne is an academic researcher from Hannover Medical School. The author has contributed to research in topics: Diabetes mellitus & Type 1 diabetes. The author has an hindex of 51, co-authored 240 publications receiving 8707 citations. Previous affiliations of Thomas Danne include Boston Children's Hospital & Humboldt University of Berlin.
Papers
More filters
Journal ArticleDOI
Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp
Moshe Phillip,Tadej Battelino,Eran Atlas,Olga Kordonouri,Natasa Bratina,Shahar Miller,Torben Biester,Magdalena Avbelj Stefanija,Ido Muller,Revital Nimri,Thomas Danne +10 more
TL;DR: Patients at a diabetes camp who were treated with an artificial-pancreas system had less nocturnal hypoglycemia and tighter glucose control than when they were treating with a sensor-augmented insulin pump.
Journal ArticleDOI
Good Metabolic Control Is Associated With Better Quality of Life in 2,101 Adolescents With Type 1 Diabetes
Hilary Hoey,Henk-Jan Aanstoot,Francesco Chiarelli,Denis Daneman,Thomas Danne,Harry Dorchy,Michael Fitzgerald,Patrick Garandeau,Stephen Greene,Reinhard W. Holl,Philip Hougaard,Eero A. Kaprio,Mirjana Kocova,Helle Lynggaard,Pedro Martul,Nobuo Matsuura,Hannah McGee,Henrik B. Mortensen,Kenneth Robertson,Eugen J. Schoenle,Oddmund Søvik,Peter G.F. Swift,Rosa Maria Tsou,Maurizio Vanelli,Jan Åman +24 more
TL;DR: Lower HbA(1c) was significantly associated with better adolescent-rated QOL on all four subscales and with lower perceived family burden as assessed by parents and health professionals.
Journal ArticleDOI
Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes.
Moshe Phillip,Tadej Battelino,Henry Rodriguez,Thomas Danne,Francine R. Kaufman,Adolescent Diabetes +5 more
TL;DR: There is still debate among diabetes care practitioners around the world as to whether CSII has advantages over MDI in terms of reduction in A1C levels, occurrence of severe hypoglycemic events, episodes of diabetic ketoacidosis (DKA), and frequency of hospitalizations in young patients.
Journal ArticleDOI
Persistent Differences Among Centers Over 3 Years in Glycemic Control and Hypoglycemia in a Study of 3,805 Children and Adolescents With Type 1 Diabetes From the Hvidøre Study Group
Thomas Danne,Henrik B. Mortensen,Philip Hougaard,Helle Lynggaard,Henk-Jan Aanstoot,Francesco Chiarelli,Denis Daneman,Harry Dorchy,Patrick Garandeau,Stephen Greene,Hilary Hoey,Reinhard W. Holl,Eero A. Kaprio,Mirjana Kocova,Pedro Martul,Nobuo Matsuura,Kenneth Robertson,Eugen J. Schoenle,Oddmund Søvik,Peter G.F. Swift,Rosa Maria Tsou,Maurizio Vanelli,Jan Åman +22 more
TL;DR: Feedback and comparison of HbA(1c) levels led to an intensification of insulin therapy in most centers, but improved glycemic control in only a few, revealing significant outcome differences among large international pediatric diabetes centers.
Journal ArticleDOI
ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents
David B. Dunger,Mark A. Sperling,Carlo L. Acerini,Desmond J. Bohn,Denis Daneman,Thomas Danne,Nicole Glaser,Ragnar Hanas,Raymond L. Hintz,Lynne L. Levitsky,Martin O. Savage,Robert C. Tasker,Joseph I. Wolfsdorf +12 more
TL;DR: There is debate as to whether physicians treating DKA can prevent or predict the occurrence of cerebral oedema, and the appropriate site(s) for children with DKA to be managed.